Parker is a member of the Secretary of State for Health's technology advisory board. He is currently Chief Commercial & Partnerships Officer at Genomics England. Previously, Parker was Entrepreneur in Residence at the Biotech and Technology venture funds backed by Fidelity, F-Prime and Eight Roads. He led an investment and was placed for a year into Owkin, a machine learning start-up that supports academic and pharmaceutical research in tumour evolution and heterogeneity in cancer. Parker also worked in technology leadership roles in the NHS.